IRIS
SOLINAS, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.232
AS - Asia 2.791
EU - Europa 2.022
SA - Sud America 1.436
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 11
Totale 11.608
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.115
BR - Brasile 1.258
SG - Singapore 1.110
CN - Cina 977
UA - Ucraina 700
IT - Italia 368
DE - Germania 255
SE - Svezia 235
HK - Hong Kong 224
VN - Vietnam 175
FI - Finlandia 110
FR - Francia 109
GB - Regno Unito 101
AR - Argentina 65
IN - India 49
TR - Turchia 40
CA - Canada 38
BD - Bangladesh 35
RU - Federazione Russa 30
IQ - Iraq 28
UZ - Uzbekistan 27
MX - Messico 26
VE - Venezuela 26
ZA - Sudafrica 24
CO - Colombia 22
EC - Ecuador 22
JP - Giappone 21
PK - Pakistan 20
BE - Belgio 19
MA - Marocco 19
JM - Giamaica 14
NL - Olanda 14
CL - Cile 13
PL - Polonia 13
AE - Emirati Arabi Uniti 11
AU - Australia 11
DZ - Algeria 11
TN - Tunisia 11
ES - Italia 10
HN - Honduras 10
PE - Perù 9
PY - Paraguay 9
ID - Indonesia 8
KE - Kenya 8
RO - Romania 8
AZ - Azerbaigian 6
NP - Nepal 6
OM - Oman 6
PS - Palestinian Territory 6
UY - Uruguay 6
AT - Austria 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
IE - Irlanda 5
JO - Giordania 5
LT - Lituania 5
BG - Bulgaria 4
BY - Bielorussia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
MY - Malesia 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
AL - Albania 3
AO - Angola 3
BW - Botswana 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PA - Panama 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EU - Europa 2
GP - Guadalupe 2
GR - Grecia 2
HU - Ungheria 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
SD - Sudan 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
KW - Kuwait 1
Totale 11.576
Salva come PNG Salva come JPEG
Città #
Dallas 1.055
Chandler 630
Singapore 578
Jacksonville 420
San Jose 346
Ashburn 312
Hong Kong 224
Council Bluffs 217
Princeton 215
Nanjing 181
Dearborn 158
Beijing 132
Santa Clara 119
Columbus 110
São Paulo 106
Wilmington 105
Lauterbourg 93
Ann Arbor 67
Nanchang 67
Shanghai 65
Boardman 64
Ho Chi Minh City 64
Los Angeles 58
Milan 56
Hanoi 41
Hebei 40
Shenyang 34
Woodbridge 34
Changsha 31
Tianjin 31
Andover 29
Brasília 29
Rio de Janeiro 29
Belo Horizonte 28
Jiaxing 26
Sassari 26
Buffalo 24
Rome 22
Tashkent 22
Hangzhou 21
Tokyo 21
Miano 20
New York 19
Porto Alegre 19
Brussels 18
Kunming 17
Norwalk 17
Jinan 16
Johannesburg 15
Curitiba 14
Naples 14
Baghdad 13
Phoenix 13
Toronto 13
Uberlândia 13
Campinas 12
Frankfurt am Main 12
Goiânia 12
Amsterdam 11
Atlanta 11
Chennai 11
Houston 11
Orem 11
Warsaw 11
Betim 10
Noicattaro 10
Ribeirão Preto 10
Salvador 10
Seattle 10
Sorocaba 10
Caruaru 9
Caxias do Sul 9
Da Nang 9
Denver 9
Florence 9
Fortaleza 9
Nuremberg 9
Quito 9
Santo André 9
Brooklyn 8
Catania 8
Guarulhos 8
Haiphong 8
London 8
Marrùbiu 8
Medellín 8
Montreal 8
Munich 8
Santiago 8
São Bernardo do Campo 8
Auburn Hills 7
Bari 7
Contagem 7
Duque de Caxias 7
Joinville 7
Kingston 7
Lahore 7
Ningbo 7
Poplar 7
Recife 7
Totale 6.552
Salva come PNG Salva come JPEG
Nome #
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 200
ARFI (acoustic radiation force impulse imaging) elastography in the liver fibrosis evaluation in HCV correlated chronic liver disease 178
Acute hepatitis with bridging necrosis due to hydralazine intake. Report of a case 175
CHANGES OF SERUM 2-5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS C 159
Skin Reaction in Antiviral therapy for Chronic Hepatitis C: A role for Polyethylene Glycol Interferon? 158
Autoimmunity in interferon treated patients with viral chronic liver disease of different etiologies 155
ASSESSMENT OF VARICEAL PRESSURE WITH AN ENDOSCOPIC BALLOOON: EFFECTS OF PHARMACOLOGICAL THERAPY 151
A 15 year old girl with fever, jaundice, haemolysis, and sudden clinical deterioration 150
Changes of serum 2-5 olygoadenylate synthetase during interferon treatmnet of chronic hepatitis C 146
Alterazioni degli indici di funzionalità tiroidea nelle epatopatie croniche. 146
A randomized controlled trial of interferon alpha-2b as therapy for chronic non-A, non-B hepatitis 145
Alteration in thyrotropin (TSH), Prolactin (PRL) and Growth Hormone (GH) secretions in chronic alcoholism and in liver cirrhosis. 145
Antibody to Hepatitis B Surface Antigen in chronic liver disease 143
Alpha-fetoprotein and Hepatitis B Virus infection in chronic liver disease 141
Autoantibodies and response to alpha interferon in patients with chronic viral hepatitis 141
The role of pre-coreHBV mutants on the long-term outcome of chronic HBV hepatitis 141
Alanine amino-transferase, Alpha-fetoprotein, hepatocellular necrosis and regeneration in chronic liver disease 138
Alanic transferase, Alphafetoprotein, hepatocellular necrosis and regeneration in chronic liver disease. 135
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients 134
CARRIER DETECTION AND EARLY DIAGNOSIS OF WILSON'S DISEASE BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS 133
Aspetti di terapia delle epatiti croniche da virus B e non-A,non-B 133
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 132
Patterns of respnse during therapy with interferon and outcome of of retreatment with interferon plus ribavirin 130
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 129
The tumour microenvironment and immune milieu of cholangiocarcinoma 127
Chronic liver disease, alcohol consumption and HBsAg antigen in Italy: a multi-regional control study 127
Lichen planus associated with anti-liver-kidney mocrosome-positive chronic active hepatitis and hyperthyroidism 126
Course of patients coinfected with HIV and hepatotropic viruses 124
PRE-CORE MUTANTS AND RESPONSIVENESS TO INTERFERON IN CHRONIC HEPATITIS B 123
Interferon therapy for chronic hepatitis C 122
T lymphocyte subsets in parenteral and non-parenteral heroin abusers in Britain 122
Changes of serum 2-5- olygoadenilate synthetase during interferon therapy in patients with chronic HCV hepatitis 120
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 120
Reazioni cutanee da farmaco: manifestazione eczema-like in corso di terapia antivirale per epatite da virus C 119
Aspetti della diagnostica delle infezioni croniche da virus dell'epatite B 119
Thymic hormones in the treatment of chronic HBV infection 119
Porto-hepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitits C virus infection 118
Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin 118
The problem of cancer diagnosis in thyroid nodules: a study in an endemic area for goiter in North Sardinia 115
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 115
Espressione immunomorfologica e quadri sierologici dell'epatite da virus B 114
Early diagnosis of Wilsonìs Disease by DNA analysis 114
Cognitive dysfunction and hepatitis C virus infection 113
Effect of different doses (1,000,000 AND 3,000,000 units ) od interferon alfa on the ALT levels of nonAnonB patients 113
Lichen planus, chronic liver disease and immunologic involvement 109
Systemic amyloidosis rapidly progressing to liver failure and hepato-renal syndrome. Report of a case 108
Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A, non-B hepatitis. A randomized controlled trial 106
Systemic lupus erythematosus in a patient with chronic hepatitis C 105
The long lasting course of chronic hepatitis C infected patients treated with interferon alfa-2b 105
Identification of Mycobacterium avium subsp paratuberculosis in biopsy specimens from patients with Crohn\'s disease identified by in situ hybridization 104
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) 104
Identification of Mycobacterium avium subp. paratuberculosis in biopsies from patients with Crohn\'s disease identified by in situ hybridization 103
Growth hormone (GH) secretion in hepatic encephalopathy 102
Twenty-four novel mutations in Wilson Disease of predomintaly Italian origin 101
Impaired thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) in hepatic encephalopathy 101
Pituitary secretion in hepatic encephalopathy 101
Epatite cronica in pazienti con coinfezione multipla HIV-Virus epatotropi 101
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study 100
High resolution-magic angle spinning (HR-MAS)-NMR based metabolomic fingerprints of early and recurrent hepatocellular carcinoma 100
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin-releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 100
tHE LONG-TERM VARICEAL PRESSURE RESPONSE TO NADOLOL ALONE AND NADOLOL PLUS ISOSORBIDE MONONITRATE 99
us-GUIDED DIRECT TRANS-HEPATIC MEASUREMENT OF THE VENOUS PORTAL GRADIENT: A NEW APPROACH TO EVALUATE PORTAL HYPERTENSION 99
Impaired thyrotrophin (TSH) response to thyrotrophin releasing hormone (TRH) in hepatic encephalopathy 99
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the study of liver transplantation 98
M. paratuberculosis may cause Crohn’s disease 97
Occurrence of hepatocellular carcinoma and decompensation in Western patients with cirrhosis type B 96
Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection 96
MOLECULAR PATHOLOGY AND HAPLOTYPE ANALYSIS OF WILSON DISEASE IN MEDITERRANEAN POPULATIONS 95
Receptors for polymerized human serum albumin 94
LONG-TERM RESPONSE TO INTERFERON ALFA RE-TREATMENT IN CHRONIC HEPATITIS C 94
HBsAg carrier and liver disease 94
Enfermedad de Erdheim-Chester: reporte de 2 casos 93
Circulating immune complexes during acute viral hepatitis type B: an attempt to detect HBsAg as their antigenic component by means of direct immunofluorescence on Raji cells 93
Immune complexes and complement system in HBsAg positive liver diseases 92
Free thyroid hormone concentration in chronic alcoholes with liver steatosis. M. Langer, S. Rassu, P.P. 92
TSH secretion in patients with hepatic encephalopathy 91
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary centres in Europe 90
Sex steroids and sex hormone binding globulin in males with chronic alcoholism and liver cirrhosis 90
Hepatic hemodynamics and liver function: comparison of a six month course of nadolol and octreotide 90
Polymerase chain reaction assay for detection of Hepatitis B Virus DNA in the serum of HBsAg/antiHBe positive subjects 90
Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia 89
Marcatori del virus dell'epatite B, stato della replicazione virale condizioni cliniche associate 88
Livelli sierici delle frazioni C3 e C4 del complemento in corso di epatopatia 88
Serum Markers of HBV infection and alphafetorprotein in chronic non malignant liver disease. 88
Interferon alpha therapy in sicilian and sardinan polytransfused thalassemic patients with chronic hepatitis C 87
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alpha 2b 86
High resolution-magic angle spinning (HR-MAS) NMR-based metabolomic fingerprinting of early and recurrent hepatocellular carcinoma 85
Hepatitis D Virus infection in parenteral drug abusers 85
PROLONGED TREATMENT (2YEARS) WITH DIFFERENT DOSES (3 VS 6 MU) OF INTERFERON ALFA2B FOR CHRONIC HEPATITIS C 85
Imaging e valutazione emodinamica nella diagnostica epatologica. Emodinamica epatica invasiva 84
Characterization of Hepatitis B Virus Core region DNA in circulating Dane particles using direct sequencing of single stranded template generated by asymmetric polymerase chain reaction 84
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis 83
The predictive value of free thyroid hormones in patients with liver cirrhosis 82
Recurrent Hepatitis Delta Virus infection after liver transplantation 82
Free thyroid hormones and chronic liver disease 82
Correlazione tra aspetti istologici e valori sierici di alfafetoproteina in epatopatie croniche HBV positive. 80
Longitudinal study of anti-HBe and DNA polymerase positive patients with chronic liver disease 80
Il trattamento con levamisolo in corso di epatite cronica attiva 78
Late diagnosis of Wilson's Disease: a single center experience over two decades 77
The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson Disease 77
Totale 11.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.003
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022406 0 0 0 2 3 5 37 34 52 14 50 209
2022/20231.182 113 58 15 183 155 206 0 162 214 12 34 30
2023/2024180 66 21 5 10 23 1 0 9 0 0 9 36
2024/20252.595 24 15 175 43 119 57 206 524 950 334 85 63
2025/20263.375 91 907 328 503 230 312 450 164 188 117 69 16
2026/20271.165 74 331 312 448 0 0 0 0 0 0 0 0
Totale 11.608